JP5626975B2 - Radiation exposure protection device - Google Patents

Radiation exposure protection device Download PDF

Info

Publication number
JP5626975B2
JP5626975B2 JP2010182700A JP2010182700A JP5626975B2 JP 5626975 B2 JP5626975 B2 JP 5626975B2 JP 2010182700 A JP2010182700 A JP 2010182700A JP 2010182700 A JP2010182700 A JP 2010182700A JP 5626975 B2 JP5626975 B2 JP 5626975B2
Authority
JP
Japan
Prior art keywords
radiation
front panel
shielding plate
subject
panel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2010182700A
Other languages
Japanese (ja)
Other versions
JP2012042292A (en
Inventor
正則 白水
正則 白水
信義 大屋
信義 大屋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Technos Corp
Original Assignee
Chugai Technos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Technos Corp filed Critical Chugai Technos Corp
Priority to JP2010182700A priority Critical patent/JP5626975B2/en
Publication of JP2012042292A publication Critical patent/JP2012042292A/en
Application granted granted Critical
Publication of JP5626975B2 publication Critical patent/JP5626975B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Description

本発明は、ポジトロン標識薬剤など放射性薬剤を被験者に投与する際に、医療従事者が放射線に被曝することを防止又は低減させる放射線被曝防護装置に関する。   The present invention relates to a radiation exposure protection device that prevents or reduces exposure of a medical worker to radiation when a radioactive drug such as a positron-labeled drug is administered to a subject.

今日、がんの診断にPET(Positron Emission Tomography)診断と呼ばれるポジトロン断層撮影法が多く利用されている。この診断方法は、がん細胞がぶどう糖を消費しやすい性質を利用したものであり、ぶどう糖に似たポジトロンを放出する放射性薬剤、例えば18F−FDGを被験者に投与し、ポジトロンと電子とが結合するとき放出するガンマ線を検出し、がん細胞の位置、大きさ等を診断する。現在、PET診断で使用する放射性薬剤の投与には、放射性薬剤を自動投与する装置が多く使用され、装置開発も活発に行われている(例えば特許文献1参照、特許文献2参照、非特許文献1参照)。   Today, positron emission tomography called PET (Positron Emission Tomography) diagnosis is often used for cancer diagnosis. This diagnostic method utilizes the property that cancer cells are likely to consume glucose. A radiopharmaceutical that releases positrons similar to glucose, such as 18F-FDG, is administered to the subject, and the positrons and electrons are combined. Sometimes gamma rays emitted are detected to diagnose the location and size of cancer cells. At present, many devices for automatically administering a radiopharmaceutical are used for administration of a radiopharmaceutical used in PET diagnosis, and device development is actively carried out (for example, see Patent Document 1, Patent Document 2, Non-patent Document). 1).

放射性薬剤自動投与装置は、一般的に、筐体内に放射性薬剤が密閉保存された容器を収納し、分注ノズルを用いて所定量の放射性薬剤を吸い出し、所定の容器等に保持した後、注射針を介して被験者に投与する。筐体内には、鉛などからなる放射線遮蔽体が設けられ、放射性薬剤等は、この放射線遮蔽体内に収納されており、放射性薬剤自動投与装置から外部に放射線が放出することを防止できる構造となっている。しかしながら投与に使用される注射針及び注射針と放射性薬剤自動投与装置とを結ぶチューブは、被験者毎に取替えられるため、通常、放射線を遮蔽する手段が講じられていない。   In general, an automatic radiopharmaceutical administration device stores a container in which a radiopharmaceutical is hermetically stored in a housing, sucks out a predetermined amount of the radiopharmaceutical using a dispensing nozzle, holds it in a predetermined container, and then injects it. Administer to subject via needle. The housing is provided with a radiation shield made of lead or the like, and the radiopharmaceutical or the like is housed in the radiation shield so that radiation can be prevented from being released to the outside from the radiopharmaceutical automatic administration device. ing. However, since the injection needle used for administration and the tube connecting the injection needle and the automatic radiopharmaceutical administration device are replaced for each subject, no means for shielding radiation is usually taken.

このような放射性薬剤自動投与装置を使用する場合には、医療従事者が被曝しないように、通常、放射性薬剤自動投与装置と被験者との間に放射線を遮蔽可能な衝立が設置される(例えば非特許文献1参照)。このような衝立は従来から放射線防護装置、X線防護衝立として使用されている(例えば特許文献3参照)。   When such an automatic radiopharmaceutical administration device is used, a screen that can shield radiation is usually installed between the radiopharmaceutical automatic administration device and a subject so as not to expose the medical staff (for example, non-radioactive agents). Patent Document 1). Such a partition is conventionally used as a radiation protection device and an X-ray protection partition (see, for example, Patent Document 3).

特開2008−212201号公報JP 2008-212201 A 特開2008−302092号公報JP 2008-302092 A 登録実用新案第3033001号公報Registered Utility Model No. 3033001

http://www.universalgiken.jp/seihin/seihin-bougo.htmlhttp://www.universalgiken.jp/seihin/seihin-bougo.html

従来から使用されている放射性薬剤自動投与装置と被験者との間に設置される衝立に関しては、被曝及び作業性に関する課題が指摘されている。医療従事者は、放射性薬剤を投与中、被験者の様子あるいは放射性薬剤の漏洩がないことなどを確認する必要があるが、従来の衝立はこの点が十分に考慮されていないため、医療従事者は被験者の様子を確認するために衝立の反対側にいる被験者を覗き込む必要が生じ、結果、被曝してしまう。また、医療従事者は、放射性薬剤を投与中は、放射性薬剤自動投与装置側にいるが、放射性薬剤自動投与装置本体と被験者とを結ぶチューブ及び注射針には放射線を遮蔽する手段が講じられていないため、この部分から放出する放射線に被曝する恐れがある。また放射性薬剤自動投与装置と被験者との間に衝立を設置すると、医療従事者は、被験者に注射針を刺す場合、衝立の反対側にいる被験者のところに移動して行い、注射針を刺した後は、また放射性薬剤自動投与装置側に戻って来る必要がある。このように従来の衝立は、医療従事者の移動あるいは作業をする上では障害となっている。これらのことから、医療従事者がより被曝しにくく、作業性に優れる放射線被曝防護装置が求められている。この放射線被曝防護装置を安価に製作できることが好ましいことは改めて言うまでもない。   With respect to a screen installed between a radiopharmaceutical automatic administration device and a subject used conventionally, problems relating to exposure and workability have been pointed out. While medical personnel are required to confirm the state of the subject or the absence of leakage of radiopharmaceuticals during administration of radiopharmaceuticals, the conventional screens do not fully consider this point. In order to confirm the state of the subject, it is necessary to look into the subject on the opposite side of the screen, and as a result, the subject is exposed. While medical personnel are on the side of the automatic radiopharmaceutical administration device during administration of the radiopharmaceutical, a means for shielding radiation is provided on the tube and injection needle connecting the radiopharmaceutical automatic administration device main body and the subject. Therefore, there is a risk of exposure to radiation emitted from this part. In addition, when a screen is installed between the radiopharmaceutical automatic administration device and the subject, the medical staff moves the subject to the subject on the opposite side of the screen and inserts the needle when inserting the needle into the subject. After that, it is necessary to return to the radiopharmaceutical automatic administration device side again. Thus, the conventional screen is an obstacle to the movement or work of medical staff. For these reasons, there is a need for a radiation exposure protection device that is less likely to be exposed to medical personnel and that is excellent in workability. It goes without saying that it is preferable to be able to manufacture this radiation exposure protection device at low cost.

本発明の目的は、放射性薬剤を投与する際に使用する、医療従事者の放射線被曝をより低減可能で作業性に優れ使い易い放射線被曝防護装置を提供することである。   An object of the present invention is to provide a radiation exposure protection device that can be used when administering a radiopharmaceutical, can reduce the radiation exposure of a medical worker, has excellent workability, and is easy to use.

請求項1に記載の本発明は、放射性薬剤投与装置を介して被験者に放射性薬剤を投与する際に使用する、移動可能な衝立式の放射線被曝防護装置であって、椅子に着座した被験者が腕を挿入する開口部が設けられた放射線を遮蔽する正面パネルと、放射性薬剤投与装置の高さに合わせて設けられた放射性薬剤投与装置を操作可能な開口部を有する放射線を遮蔽する側面パネルと、前記正面パネルに設けられた開口部の下端部の位置に合わせ、前記正面パネルの表裏に取付けられた被験者の腕を置くためのテーブルと、前記正面パネル及び側面パネルの下部に設けられたキャスターと、を含み、前記正面パネル及び側面パネルは共に、少なくとも開口部の下端から上部が透明であり、前記正面パネルと側面パネルがL字状に配置、連結されていることを特徴とする放射線被曝防護装置である。   The present invention according to claim 1 is a movable screen-type radiation exposure protection device used when a radiopharmaceutical is administered to a subject via a radiopharmaceutical administration device, wherein the subject sitting on a chair has an arm. A front panel that shields radiation provided with an opening for inserting the radiation, a side panel that shields radiation having an opening capable of operating the radiopharmaceutical administration device provided in accordance with the height of the radiopharmaceutical administration device, and In accordance with the position of the lower end of the opening provided in the front panel, a table for placing the subject's arm attached to the front and back of the front panel, and casters provided at the lower part of the front panel and the side panel Both the front panel and the side panel are transparent at least from the lower end of the opening, and the front panel and the side panel are arranged and connected in an L shape. It is radiation exposure protection device according to claim.

請求項2に記載の本発明は、請求項1に記載の放射線被曝防護装置において、前記正面パネルは、上半面が透明な放射線遮蔽板、下半面が不透明な放射線遮蔽板からなり、上半面を覆う放射線遮蔽板の下部に前記開口部が設けられ、前記側面パネルは、上方部が透明な放射線遮蔽板、他部が不透明な放射線遮蔽板からなり、上方部放射線遮蔽板の下部に前記開口部が設けられていることを特徴とする。   According to a second aspect of the present invention, in the radiation exposure protection apparatus according to the first aspect, the front panel includes a radiation shielding plate having a transparent upper half surface and a radiation shielding plate having an opaque lower half surface. The opening is provided in a lower part of a radiation shielding plate to be covered, and the side panel is composed of a transparent radiation shielding plate in the upper part and an opaque radiation shielding plate in the other part, and the opening is formed in the lower part of the upper radiation shielding plate. Is provided.

請求項3に記載の本発明は、請求項1又は2に記載の放射線被曝防護装置において、前記正面パネルの被験者が対面する方を表側、その反対側を裏側としたとき、前記正面パネルと前記側面パネルの継ぎ目が前記正面パネルの裏側になるように、前記正面パネルと前記側面パネルが配置、連結されていることを特徴とする。 The radiation exposure protection apparatus according to claim 1 or 2, wherein the radiation exposure protection apparatus according to claim 1 or 2 is such that when the subject facing the front panel faces the front side and the opposite side is the back side, The front panel and the side panel are arranged and connected so that the joint of the side panel is on the back side of the front panel.

請求項4に記載の本発明は、請求項1から3のいずれか1に記載の放射線被曝防護装置において、さらに放射性薬剤を投与中の被験者の腕に上方から被せ使用する、透明な放射線遮蔽板で形成された腕カバーを含むことを特徴とする。   A fourth aspect of the present invention is the radiation exposure protection apparatus according to any one of the first to third aspects, wherein the radiation exposure protection device is further used by covering the arm of the subject who is administering the radiopharmaceutical from above. And an arm cover formed by the method described above.

請求項5に記載の本発明は、請求項1から4のいずれか1に記載の放射線被曝防護装置において、前記正面パネルの被験者が対面する方を表側、その反対側を裏側としたとき、さらに前記正面パネルの表側中央部に設置され、被験者の体内から放出される放射線量を測定する放射線量検出器と、前記正面パネルの裏側に設置され、前記放射線量検出器で測定した放射線量を表示する表示器と、を含むことを特徴とする。 The radiation exposure protection device according to any one of claims 1 to 4, wherein the subject of the front panel facing the subject is the front side and the opposite side is the back side. A radiation dose detector that is installed at the front center of the front panel and measures the radiation dose emitted from the body of the subject, and a radiation dose that is installed on the back side of the front panel and measured by the radiation dose detector is displayed. And a display device.

本発明の放射線被曝防護装置は、正面パネルと側面パネルがL字状に配置された放射線を遮蔽可能な衝立式の放射線被曝防護装置であるので、放射性薬剤投与装置と被験者とを結ぶチューブから放出される放射線を側面パネルで遮蔽することが可能であり、従来の衝立に比べ医療従事者の放射線被曝をより低減することができる。また正面パネルには被験者が腕を挿入する開口部及び腕を置くためのテーブルが設けられ、さらに開口部から上部が透明なので、医療従事者は、被験者側に移動することなく正面パネルの内側から被験者の腕に注射針を刺すことができる。さらに側面パネルには、放射性薬剤投与装置を操作するための開口部も設けられ、さらに開口部から上部が透明なので、医療従事者は、放射性薬剤投与装置側に移動することなく側面パネルの内側から放射性薬剤投与装置を操作することができる。また正面パネルの上方部が透明なので、医療従事者は、正面パネルの内側から被験者の様子又は投与の様子を視認することができる。上記のように本発明の放射線被曝防護装置は、正面パネル及び側面パネルの内側で作業、操作又は監視をすることができるので放射線被曝をより低減可能で作業性に優れ使い易い。   The radiation exposure protection device of the present invention is a screen-type radiation exposure protection device capable of shielding radiation in which a front panel and a side panel are arranged in an L shape, and is thus released from a tube connecting a radiopharmaceutical administration device and a subject. It is possible to shield the emitted radiation with the side panel, and the radiation exposure of the medical staff can be further reduced as compared with the conventional screen. Also, the front panel is provided with an opening for the subject to insert the arm and a table for placing the arm, and since the upper part is transparent from the opening, the medical staff can move from the inside of the front panel without moving to the subject side. A needle can be inserted into the arm of the subject. Furthermore, the side panel is also provided with an opening for operating the radiopharmaceutical administration device, and since the upper part is transparent from the opening, the medical staff can move from the inside of the side panel without moving to the radiopharmaceutical administration device side. The radiopharmaceutical administration device can be operated. Moreover, since the upper part of a front panel is transparent, the medical worker can visually recognize a test subject's state or the mode of administration from the inside of a front panel. As described above, the radiation exposure protection apparatus of the present invention can be operated, operated or monitored inside the front panel and the side panel, so that radiation exposure can be further reduced, and workability is excellent and easy to use.

また本発明によれば、前記正面パネルは、上半面が透明な放射線遮蔽板、下半面が不透明な放射線遮蔽板からなり、上半面を覆う放射線遮蔽板の下部に前記開口部が設けられ、前記側面パネルは、上方部が透明な放射線遮蔽板、他部が不透明な放射線遮蔽板からなり、上方部放射線遮蔽板の下部に前記開口部が設けられているので、パネルを容易かつ安価に製作することができ、また透明な領域が広く視認性に優れる。   According to the invention, the front panel is composed of a radiation shielding plate whose upper half surface is transparent and a radiation shielding plate whose lower half surface is opaque, and the opening is provided below the radiation shielding plate covering the upper half surface. The side panel consists of a transparent radiation shielding plate in the upper part and an opaque radiation shielding plate in the other part, and the opening is provided in the lower part of the upper radiation shielding plate, so that the panel can be manufactured easily and inexpensively. In addition, the transparent region is wide and has excellent visibility.

また本発明によれば、正面パネルと側面パネルの継ぎ目が正面パネルの裏側になるように正面パネルと側面パネルが配置されているので、被験者から放出される放射線が継ぎ目を通じて正面パネルの内側に入り込むことを防止できる。このように正面パネルと側面パネルを配置することで医療従事者の放射線被曝をより確実に低減させることができる。   Further, according to the present invention, since the front panel and the side panel are arranged so that the joint between the front panel and the side panel is on the back side of the front panel, the radiation emitted from the subject enters the inside of the front panel through the joint. Can be prevented. By arranging the front panel and the side panel in this way, the radiation exposure of the medical staff can be more reliably reduced.

また本発明によれば、本発明の放射線被曝防護装置は、放射性薬剤を投与中の被験者の腕に上方から被せ使用する腕カバーを備えるので、医療従事者の放射線被曝をより確実に低減させることができる。腕カバーを使用するとき、腕カバーは透明な放射線遮蔽板で形成されているので、医療従事者は放射性薬剤の漏洩、注射針の抜け落ちなどを容易に視認することができる。   Further, according to the present invention, the radiation exposure protection apparatus of the present invention includes the arm cover that is used by covering the arm of the subject who is administering the radiopharmaceutical from above, so that the radiation exposure of the medical staff can be more reliably reduced. Can do. When the arm cover is used, the arm cover is formed of a transparent radiation shielding plate, so that the medical staff can easily visually recognize the leakage of the radiopharmaceutical and the dropping of the injection needle.

また本発明によれば、正面パネルの表側に被験者の体内から放出される放射線量を測定する放射線量検出器が設置され、その表示器が正面パネルの裏側に設置されている。このため医療従事者は、被験者の体内に放射性薬剤が入っていることを正面パネルの内側から容易に確認することができるので使い勝手がよい。   Further, according to the present invention, the radiation dose detector for measuring the radiation dose emitted from the body of the subject is installed on the front side of the front panel, and the indicator is installed on the back side of the front panel. For this reason, the medical staff can easily confirm from the inside of the front panel that the radiopharmaceutical is contained in the body of the subject.

本発明の実施の一形態としての放射線被曝防護装置1の斜視図である。1 is a perspective view of a radiation exposure protection device 1 as an embodiment of the present invention. 図1の放射線被曝防護装置1の正面パネル3の正面図及び側面図である。It is the front view and side view of the front panel 3 of the radiation exposure protection apparatus 1 of FIG. 図1の放射線被曝防護装置1の正面パネル3の放射線遮蔽板13と放射線遮蔽板15との接続要領を示す部分断面図である。It is a fragmentary sectional view which shows the connection point of the radiation shielding board 13 and the radiation shielding board 15 of the front panel 3 of the radiation exposure protection apparatus 1 of FIG. 図1の放射線被曝防護装置1の側面パネル5の正面図及び側面図である。It is the front view and side view of the side panel 5 of the radiation exposure protection apparatus 1 of FIG. 図1の放射線被曝防護装置1の使用例を示す平面図である。It is a top view which shows the usage example of the radiation exposure protection apparatus 1 of FIG. 図1の放射線被曝防護装置1といっしょに使用可能な腕カバー80の斜視図である。It is a perspective view of the arm cover 80 which can be used with the radiation exposure protection apparatus 1 of FIG.

図1は、本発明の実施の一形態としての放射線被曝防護装置1の斜視図、図2は、放射線被曝防護装置1の正面パネル3の正面図(a)及び側面図(b)、図3は、正面パネル3の放射線遮蔽板13と放射線遮蔽板15との接続要領を示す部分断面図、図4は、放射線被曝防護装置1の側面パネル5の正面図(a)及び側面図(b)、図5は、放射線被曝防護装置1の使用例を示す平面図である。   FIG. 1 is a perspective view of a radiation exposure protection device 1 as an embodiment of the present invention, and FIG. 2 is a front view (a), a side view (b), and FIG. 3 of a front panel 3 of the radiation exposure protection device 1. Fig. 4 is a partial cross-sectional view showing a connection procedure between the radiation shielding plate 13 and the radiation shielding plate 15 of the front panel 3, and Fig. 4 is a front view (a) and a side view (b) of the side panel 5 of the radiation exposure protection device 1. FIG. 5 is a plan view showing an example of use of the radiation exposure protection apparatus 1.

放射線被曝防護装置1は、ポジトロン標識薬剤などの放射性薬剤を放射性薬剤投与装置200を介して被験者100に投与する際に使用する、放射線を遮蔽可能な2つのパネルがL字型に配置された移動可能な衝立式の放射線被曝防護装置である。   The radiation exposure protection device 1 is a movement in which two panels capable of shielding radiation are arranged in an L shape, which is used when a radiopharmaceutical such as a positron-labeled drug is administered to a subject 100 via the radiopharmaceutical administration device 200. Possible screen-type radiation exposure protection device.

放射線被曝防護装置1は、被験者100が対面する正面パネル3、放射性薬剤投与装置200を遮蔽する側面パネル5、被験者100が放射性薬剤を投与される腕を置くテーブル7、9、放射線被曝防護装置1を移動させるためのキャスター11を含む。以下、正面パネル3のうち被験者100が対向する面を表面31、その反対の面を裏面32、被験者100がいる側を表側又は外側、医療従事者110がいる側を裏側又は内側と記す。同様に側面パネル5のうち放射性薬剤投与装置200が設置される側の面を表面33、その反対の面を裏面34、放射性薬剤投与装置200が設置される側を表側又は外側、医療従事者がいる側を裏側又は内側と記す。   The radiation exposure protection device 1 includes a front panel 3 that the subject 100 faces, a side panel 5 that shields the radiopharmaceutical administration device 200, tables 7 and 9 on which the subject 100 puts an arm to which the radiopharmaceutical is administered, and the radiation exposure protection device 1. A caster 11 for moving the vehicle is included. Hereinafter, the surface of the front panel 3 on which the subject 100 faces is referred to as the front surface 31, the opposite surface is referred to as the back surface 32, the side where the subject 100 is present is referred to as the front side or the outside, and the side where the medical worker 110 is located is referred to as the back side or the inside. Similarly, the side of the side panel 5 on which the radiopharmaceutical administration device 200 is installed is the front surface 33, the opposite surface is the back surface 34, the side on which the radiopharmaceutical administration device 200 is installed is the front side or the outside, The side that is present is referred to as the back side or the inside.

正面パネル3は、縦長矩形状のパネルであり、被験者100に放射性薬剤が投与されるとき医療従事者110を放射線被曝から守るためのパネルである。正面パネル3は、上下に配置された2つの放射線遮蔽板13、15が連結材17を介して隙間なく連結され形成されている。上半面を覆う放射線遮蔽板13は、被験者100に放射性薬剤を投与中、正面パネル3の内側にいる医療従事者110が正面パネル3の外側にいる被験者100の様子、放射性薬剤の投与の状態を視認できるように透明な放射線遮蔽板13からなり、下部には被験者100が正面パネル3の内側に腕104を差し出すための開口部19が設けられている。正面パネル3の上端にはクッション材12が取付けられている。   The front panel 3 is a vertically long rectangular panel, and is a panel for protecting the medical worker 110 from radiation exposure when a radiopharmaceutical is administered to the subject 100. The front panel 3 is formed by connecting two radiation shielding plates 13 and 15 arranged on the upper and lower sides via a connecting member 17 without a gap. The radiation shielding plate 13 covering the upper half surface indicates the state of the subject 100 in which the medical worker 110 inside the front panel 3 is outside the front panel 3 and the state of administration of the radiopharmaceutical while the subject 100 is administering the radiopharmaceutical. It is made of a transparent radiation shielding plate 13 so that it can be visually recognized, and an opening 19 is provided at the lower part for the subject 100 to put out the arm 104 inside the front panel 3. A cushion material 12 is attached to the upper end of the front panel 3.

正面パネル3の高さは、椅子130に着座した状態の被験者100の頭102の高さに少し加算した高さ、横幅は、被験者100の肩幅に少し加算した幅である。放射性薬剤を投与中、被験者100は椅子130に着座した状態であるので、正面パネル3の大きさをこのように設定することで、放射性薬剤を投与中の被験者100から放出される放射線を遮蔽することができる。なお、正面パネル3の両側面下端部43、45にはキャスター11が取付けられ、正面パネル3の下端は床面55から5〜20mm程度浮き上がっているので、正面パネル3の高さは、この高さを考慮して決められている。この点に関しては、側面パネル5の高さ及び開口部19、20の設置高さも同じである。医療従事者110を放射線被曝から守る点からは、正面パネル3が大きいことが好ましいことは当然であるが、不必要に大きくしても放射線遮蔽性能は十分に高くならず不経済であり、また移動、設置が不便となる。正面パネル3の厚さは、医療従事者110の被曝線量が所定の値以下となるように放射線遮蔽板13、15の放射線遮蔽性能に応じて適宜決定する。   The height of the front panel 3 is a height obtained by adding a little to the height of the head 102 of the subject 100 in a state of sitting on the chair 130, and the horizontal width is a width obtained by adding a little to the shoulder width of the subject 100. Since the subject 100 is seated on the chair 130 during the administration of the radiopharmaceutical, the size of the front panel 3 is set in this way to shield the radiation emitted from the subject 100 who is administering the radiopharmaceutical. be able to. The casters 11 are attached to the lower end portions 43 and 45 on both side surfaces of the front panel 3, and the lower end of the front panel 3 is lifted by about 5 to 20 mm from the floor surface 55. It is decided in consideration of this. In this regard, the height of the side panel 5 and the installation height of the openings 19 and 20 are the same. Naturally, it is preferable that the front panel 3 is large from the viewpoint of protecting the medical staff 110 from radiation exposure, but even if it is unnecessarily large, the radiation shielding performance is not sufficiently high, which is uneconomical. Inconvenient to move and install. The thickness of the front panel 3 is appropriately determined according to the radiation shielding performance of the radiation shielding plates 13 and 15 so that the exposure dose of the medical staff 110 is a predetermined value or less.

放射線遮蔽板13は、正面パネル3の上半面を形成する部材であり、具体的には椅子130に着座した状態の被験者100の上半身をカバーできる大きさを有し、被験者100の上半身をカバーできるように配置されている。放射線遮蔽板13は、所定の放射線遮蔽性能を備えることはもちろん、被験者100に放射性薬剤を投与中、正面パネル3の内側にいる医療従事者110がこの放射線遮蔽板13を通じて正面パネル3の外側にいる被験者100の様子、放射性薬剤の投与の状態を視認できることが必要である。このため放射線遮蔽板13は、放射線遮蔽性能が十分に高くても、透視性が不十分な放射線遮蔽板は好ましくない。放射線遮蔽性能及び透視性に優れる放射線遮蔽板13としては、公知の含鉛アクリル板、含鉛プラスチック板、放射線遮蔽用鉛ガラスなどを使用することができる。   The radiation shielding plate 13 is a member that forms the upper half of the front panel 3. Specifically, the radiation shielding plate 13 has a size that can cover the upper body of the subject 100 sitting on the chair 130, and can cover the upper body of the subject 100. Are arranged as follows. Of course, the radiation shielding plate 13 has a predetermined radiation shielding performance, and during the administration of the radiopharmaceutical to the subject 100, a medical worker 110 inside the front panel 3 passes through the radiation shielding plate 13 to the outside of the front panel 3. It is necessary to be able to visually recognize the state of the subject 100 and the administration state of the radiopharmaceutical. For this reason, the radiation shielding plate 13 is not preferably a radiation shielding plate with insufficient transparency even though the radiation shielding performance is sufficiently high. As the radiation shielding plate 13 excellent in radiation shielding performance and transparency, a known lead-containing acrylic plate, lead-containing plastic plate, lead glass for radiation shielding, or the like can be used.

放射線遮蔽板13の下部中央には、ドーム状の開口部19が設けられている。この開口部19は、放射性薬剤を投与する注射針202を刺すための腕104を、被験者100が正面パネル3の内側に差し出すためのものである。開口部19は、放射線遮蔽能力がないため不必要に大きくすべきではない。一方、無理なく腕104を出し入れできる大きさは必要である。開口部19の大きさを例示すれば、高さ200mm、幅250mm程度である。   A dome-shaped opening 19 is provided in the lower center of the radiation shielding plate 13. The opening 19 is for the subject 100 to push out the arm 104 for piercing the injection needle 202 for administering the radiopharmaceutical to the inside of the front panel 3. The opening 19 should not be unnecessarily large because it has no radiation shielding capability. On the other hand, a size that allows the arm 104 to be taken in and out without difficulty is necessary. For example, the size of the opening 19 is about 200 mm in height and 250 mm in width.

放射線遮蔽板15は、正面パネル3の下半面を形成する部材であり、具体的には椅子130に着座した状態の被験者100の下半身をカバーできる大きさを有し、被験者100の下半身をカバーできるように配置されている。放射線遮蔽板15は、中心部に鉛板(図示を省略)が配置され、この鉛板を両側からステンレス板21a、21bで覆った構造である。下部に位置する放射線遮蔽板15は、上部の放射線遮蔽板13と異なり、透明な部材で構成する必要はなく、放射線遮蔽性に優れる部材であればよく、安価であればより好ましい。放射線遮蔽板15の幅、厚さは、放射線遮蔽板13と放射線遮蔽板15との間に段差ができないように上部の放射線遮蔽板13と同一に形成されている。これにより上部の放射線遮蔽板13と下部の放射線遮蔽板15との連結材17による連結が容易となり、連結部からの放射線漏洩防止対策も容易となる。また意匠的にも好ましい。放射線遮蔽板15を構成する鉛板及びステンレス板21a、21bの厚さは、放射線遮蔽能力から決めればよく、必要以上に厚くする必要はない。鉛板及びステンレス板21a、21bの厚さが薄く、これらの厚さの合計が放射線遮蔽板13の厚さに比較し小さい場合は、鉛板とステンレス板21a、21bとの間に空間を設けるようにしてもよい。   The radiation shielding plate 15 is a member that forms the lower half surface of the front panel 3. Specifically, the radiation shielding plate 15 has a size that can cover the lower body of the subject 100 while sitting on the chair 130, and can cover the lower body of the subject 100. Are arranged as follows. The radiation shielding plate 15 has a structure in which a lead plate (not shown) is arranged at the center, and the lead plate is covered with stainless steel plates 21a and 21b from both sides. Unlike the upper radiation shielding plate 13, the radiation shielding plate 15 located in the lower portion does not need to be formed of a transparent member, may be a member having excellent radiation shielding properties, and more preferably inexpensive. The width and thickness of the radiation shielding plate 15 are the same as those of the upper radiation shielding plate 13 so that there is no step between the radiation shielding plate 13 and the radiation shielding plate 15. As a result, the connection between the upper radiation shielding plate 13 and the lower radiation shielding plate 15 by the connecting member 17 is facilitated, and measures for preventing radiation leakage from the coupling portion are also facilitated. It is also preferable in terms of design. The thicknesses of the lead plate and the stainless steel plates 21a and 21b constituting the radiation shielding plate 15 may be determined from the radiation shielding ability, and need not be increased more than necessary. When the lead plate and the stainless steel plates 21a and 21b are thin and the total thickness is smaller than the thickness of the radiation shielding plate 13, a space is provided between the lead plate and the stainless steel plates 21a and 21b. You may do it.

連結材17は、上下に配置された放射線遮蔽板13と放射線遮蔽板15とをしっかり固定、連結するための部材であり、ステンレス製で断面がコ字状である。連結材17のコ字状の溝の幅は、放射線遮蔽板13及び放射線遮蔽板15の厚さとほぼ同じに設けられている。放射線遮蔽板13及び放射線遮蔽板15の両側面端部に連結材17を嵌め込み、連結材17と放射線遮蔽板13及び放射線遮蔽板15とを貫通するように取付けられたボルト23により、連結材17と放射線遮蔽板13及び放射線遮蔽板15とが一体的に連結されている。連結材17の断面形状をコ字状とすることで、連結材17と放射線遮蔽板13及び放射線遮蔽板15とをしっかりと固定することが可能であり、さらに正面パネル3の裏側に放射線が漏洩することを防止できる。放射線遮蔽板13と放射線遮蔽板15との継ぎ目部分には、図3に示すように断面がH状の鉛からなる1〜2mm程度の薄いシール部材24が取付けられ、放射線遮蔽板13と放射線遮蔽板15との継ぎ目部分からの放射線の漏洩を防いでいる。放射線遮蔽板13と放射線遮蔽板15との連結方法は、連結材17、シール部材24を使用した方法に限定されるものではなく、放射線を漏洩させることなく放射線遮蔽板13と放射線遮蔽板15とをしっかりと固定、連結できる方法であれば他の方法であってもよい。   The connecting member 17 is a member for firmly fixing and connecting the radiation shielding plate 13 and the radiation shielding plate 15 arranged above and below, and is made of stainless steel and has a U-shaped cross section. The width of the U-shaped groove of the connecting member 17 is provided approximately the same as the thickness of the radiation shielding plate 13 and the radiation shielding plate 15. A connecting member 17 is fitted into the end portions of both sides of the radiation shielding plate 13 and the radiation shielding plate 15, and bolts 23 attached so as to penetrate the connecting member 17, the radiation shielding plate 13 and the radiation shielding plate 15. The radiation shielding plate 13 and the radiation shielding plate 15 are integrally connected. By making the cross-sectional shape of the connecting member 17 U-shaped, the connecting member 17 and the radiation shielding plate 13 and the radiation shielding plate 15 can be firmly fixed, and further radiation leaks to the back side of the front panel 3. Can be prevented. As shown in FIG. 3, a thin sealing member 24 having a cross section of about 1 to 2 mm made of lead having an H shape is attached to the joint portion between the radiation shielding plate 13 and the radiation shielding plate 15. The leakage of radiation from the joint portion with the plate 15 is prevented. The method for connecting the radiation shielding plate 13 and the radiation shielding plate 15 is not limited to the method using the connecting member 17 and the seal member 24, and the radiation shielding plate 13 and the radiation shielding plate 15 can be used without leaking radiation. Other methods may be used as long as they can be firmly fixed and connected.

クッション材12は、スポンジ状の部材からなり、被験者100が、椅子130に着座するとき、あるいは椅子130から立ち上がるとき、ふらつき頭102あるいは体を正面パネル3にぶつけ怪我をする可能性があるため、安全確保のために設けられたものである。   The cushion material 12 is made of a sponge-like member, and when the subject 100 sits on the chair 130 or stands up from the chair 130, the head 102 or the body may be bumped against the front panel 3 to cause injury. It is provided to ensure safety.

テーブル7、9は、椅子130に着座した被験者100が放射性薬剤を投与される腕104を置くための台であり、放射線遮蔽板13の下端35にテーブル7、9の表面27が一致するように、取付け具29を介して正面パネル3に固定されている。正面パネル3の表面31に固定されたテーブル7及び正面パネル3の裏面32に固定されたテーブル9は、同じ高さで水平に取り付けられている。テーブル7は、被験者100が腕104を差し出し易いように被験者100側が円弧状にカーブしている。テーブル7、9の大きさは、被験者100が差し出した腕104を無理なく置ける大きさがあればよい。テーブル7、9の取付け高さは、椅子130に着座した被験者100が放射性薬剤を投与される腕104を無理なく置くことができる高さに設定されている。放射線遮蔽板13に設けられた開口部19は、放射線遮蔽板13の下端35を起点に設けられているので、被験者100が開口部19に腕104を差し込むと、自然とテーブル7、9の上に置くことができる。このように放射線遮蔽板13、15の取付け高さは、テーブル7、9の設置位置から決められている。   The tables 7 and 9 are tables for the subject 100 sitting on the chair 130 to place the arm 104 to which the radiopharmaceutical is administered, so that the surface 27 of the tables 7 and 9 coincides with the lower end 35 of the radiation shielding plate 13. , Fixed to the front panel 3 via a fixture 29. The table 7 fixed to the front surface 31 of the front panel 3 and the table 9 fixed to the back surface 32 of the front panel 3 are mounted horizontally at the same height. In the table 7, the subject 100 is curved in an arc shape so that the subject 100 can easily push out the arm 104. The size of the tables 7 and 9 only needs to be large enough to place the arm 104 provided by the subject 100 without difficulty. The mounting height of the tables 7 and 9 is set to a height at which the subject 100 sitting on the chair 130 can easily put the arm 104 to which the radiopharmaceutical is administered. The opening 19 provided in the radiation shielding plate 13 is provided with the lower end 35 of the radiation shielding plate 13 as a starting point. Therefore, when the subject 100 inserts the arm 104 into the opening 19, the opening 19 is naturally on the table 7 or 9. Can be put in. Thus, the mounting height of the radiation shielding plates 13 and 15 is determined from the installation positions of the tables 7 and 9.

側面パネル5は、放射性薬剤投与装置200、特にチューブ204から放出される放射線から医療従事者110を守るためのパネルであり、正面パネル3と同様に、上下に配置された2つの放射線遮蔽板14、16が連結材18を介して隙間なく連結され形成されている。上方部を覆う放射線遮蔽板14は、側面パネル5の内側にいる医療従事者110が側面パネル5の外側に設置された放射性薬剤投与装置200を操作するため透明な放射線遮蔽板からなり、下部には医療従事者110が側面パネル5の外側に設置された放射性薬剤投与装置200を操作するための開口部20が設けられている。   The side panel 5 is a panel for protecting the medical worker 110 from radiation emitted from the radiopharmaceutical administration device 200, particularly the tube 204, and similarly to the front panel 3, the two radiation shielding plates 14 arranged up and down. , 16 are connected via a connecting member 18 without gaps. The radiation shielding plate 14 that covers the upper part is a transparent radiation shielding plate for the medical worker 110 inside the side panel 5 to operate the radiopharmaceutical administration device 200 installed outside the side panel 5. The medical staff 110 is provided with an opening 20 for operating the radiopharmaceutical administration device 200 installed outside the side panel 5.

側面パネル5は、正面パネル3の一側辺37に直交するように正面パネル3と連結具38を介して連結されている。このとき側面パネル5は、正面パネル3の裏面32に当接するように配置されている。よって正面パネル3の表側から側面パネル5は見えない。側面パネル5と正面パネル3の継ぎ目39には鉛からなる数mm程度の薄いシール部材が取付けられている。側面パネル5と正面パネル3を上記のように配置することで被験者100から放出される放射線が正面パネル3と側面パネル5の継ぎ目39を通じて正面パネル3の内側に入り込むことを防止できる。これにより医療従事者110の放射線被曝をより確実に低減することができる。   The side panel 5 is connected to the front panel 3 via a connector 38 so as to be orthogonal to one side 37 of the front panel 3. At this time, the side panel 5 is disposed so as to contact the back surface 32 of the front panel 3. Therefore, the side panel 5 cannot be seen from the front side of the front panel 3. A thin sealing member made of lead and having a thickness of about several millimeters is attached to the joint 39 between the side panel 5 and the front panel 3. By arranging the side panel 5 and the front panel 3 as described above, radiation emitted from the subject 100 can be prevented from entering the inside of the front panel 3 through the joint 39 between the front panel 3 and the side panel 5. Thereby, the radiation exposure of the medical worker 110 can be reduced more reliably.

側面パネル5は、正面パネル3と同様、矩形形状であり、高さは正面パネル3と同じである。横幅は、放射性薬剤投与装置200の幅の1.2〜2倍程度の横幅とすることが好ましい。医療従事者110を放射線被曝から守る点からは大きいことが好ましいが、不必要に大きくしても放射線遮蔽性能は十分に高くならず不経済であり、また移動、設置が不便となる。側面パネル5の厚さは、医療従事者110の被曝線量が所定の値以下となるように放射線遮蔽板14、16の放射線遮蔽能力に応じて、適宜決定する。   The side panel 5 has a rectangular shape like the front panel 3 and has the same height as the front panel 3. The lateral width is preferably about 1.2 to 2 times the width of the radiopharmaceutical administration device 200. From the viewpoint of protecting the medical staff 110 from radiation exposure, it is preferable to be large, but even if it is unnecessarily large, the radiation shielding performance is not sufficiently high and it is uneconomical, and movement and installation are inconvenient. The thickness of the side panel 5 is appropriately determined according to the radiation shielding ability of the radiation shielding plates 14 and 16 so that the exposure dose of the medical staff 110 is not more than a predetermined value.

上部に配置される透明な放射線遮蔽板14は、所定の放射線遮蔽性能を備えることはもちろん、医療従事者110が側面パネル5の内側から側面パネル5の外側に設置されている放射性薬剤投与装置200の操作盤(図示省略)を操作するため、放射線遮蔽板14は、医療従事者110が放射線遮蔽板14を通じて放射性薬剤投与装置200の操作盤を容易に視認できることが必要である。このため放射線遮蔽板14は、放射線遮蔽性能が十分に高くても、透視性が不十分な放射線遮蔽板は好ましくない。放射線遮蔽性能及び透視性に優れる放射線遮蔽板14としては、公知の含鉛アクリル板、含鉛プラスチック板、放射線遮蔽用鉛ガラスなどを使用することができ、正面パネル3の放射線遮蔽板13と同じ放射線遮蔽板を使用することができる。   The transparent radiation shielding plate 14 disposed at the top has a predetermined radiation shielding performance, and the radiopharmaceutical administration device 200 in which the medical worker 110 is installed from the inside of the side panel 5 to the outside of the side panel 5. In order to operate the operation panel (not shown), it is necessary for the radiation shielding plate 14 to allow the medical worker 110 to easily see the operation panel of the radiopharmaceutical administration device 200 through the radiation shielding plate 14. For this reason, the radiation shielding plate 14 is not preferably a radiation shielding plate with insufficient transparency even though the radiation shielding performance is sufficiently high. As the radiation shielding plate 14 having excellent radiation shielding performance and transparency, a known lead-containing acrylic plate, lead-containing plastic plate, lead glass for radiation shielding, or the like can be used, which is the same as the radiation shielding plate 13 of the front panel 3. A radiation shielding plate can be used.

放射線遮蔽板14の下部中央には、放射線遮蔽板14の下端を起点に矩形状の開口部20が設けられている。この開口部20は、医療従事者110が側面パネル5の内側から放射性薬剤投与装置200の操作盤を操作するためのものであり、放射線遮蔽板14は、開口部20の下端部41、つまり放射線遮蔽板14の下端が放射性薬剤投与装置200の高さと同じ高さとなるように取付けられている。開口部20は、放射性薬剤投与装置200の操作盤を容易に操作できる大きさであればよく、一方、放射線遮蔽能力がないため不必要に大きくすべきではない。開口部20の大きさを例示すれば、横幅は、放射性薬剤投与装置200の横幅とほぼ同じとし、高さは200〜300mmとすることができる。   A rectangular opening 20 is provided at the lower center of the radiation shielding plate 14 starting from the lower end of the radiation shielding plate 14. The opening 20 is for the medical staff 110 to operate the operation panel of the radiopharmaceutical administration device 200 from the inside of the side panel 5, and the radiation shielding plate 14 is the lower end 41 of the opening 20, that is, radiation. The lower end of the shielding plate 14 is attached so as to be the same height as the radiopharmaceutical administration device 200. The opening 20 may be of a size that allows the operation panel of the radiopharmaceutical administration device 200 to be easily operated. On the other hand, the opening 20 should not be unnecessarily large because it has no radiation shielding ability. For example, the width of the opening 20 may be approximately the same as the width of the radiopharmaceutical administration device 200, and the height may be 200 to 300 mm.

放射線遮蔽板16は、側面パネル5の中央部から下方部分を形成する部材であり、正面パネル3の放射線遮蔽板15と同様の機能、構成からなる。放射線遮蔽板16は、放射線遮蔽板15と同様に中心部に鉛板が配置され、この鉛板を両側からステンレス板22a、22bで覆った構造であるが、放射線遮蔽板15に比較し、鉛板の厚さを薄くすることができる。これは放射性薬剤投与装置200が、内部に放射線遮蔽板を備え、放射性薬剤投与装置200から外部への放射線の放出を遮蔽していることによる。放射線遮蔽板16は、上端部の高さが放射性薬剤投与装置200の高さと同一となるように取付けられている。これにより放射線遮蔽板14に設けられた開口部20の下端部41の高さが放射性薬剤投与装置200の高さと同一となるので、放射性薬剤投与装置200の操作盤の操作が容易となる。   The radiation shielding plate 16 is a member that forms a lower portion from the center of the side panel 5 and has the same function and configuration as the radiation shielding plate 15 of the front panel 3. The radiation shielding plate 16 has a structure in which a lead plate is arranged in the center as in the radiation shielding plate 15 and this lead plate is covered with stainless steel plates 22a and 22b from both sides. The thickness of the plate can be reduced. This is because the radiopharmaceutical administration device 200 includes a radiation shielding plate inside and shields radiation emission from the radiopharmaceutical administration device 200 to the outside. The radiation shielding plate 16 is attached so that the height of the upper end portion is the same as the height of the radiopharmaceutical administration device 200. As a result, the height of the lower end portion 41 of the opening 20 provided in the radiation shielding plate 14 is the same as the height of the radiopharmaceutical administration device 200, so that the operation panel of the radiopharmaceutical administration device 200 can be easily operated.

放射線遮蔽板14と放射線遮蔽板16との固定、連結要領は、正面パネル3と同一である。   The fixing and connecting points between the radiation shielding plate 14 and the radiation shielding plate 16 are the same as those of the front panel 3.

キャスター11は、正面パネル3の両側面下端部43、45、側面パネル5の両側面下端部47、49に設けられている。正面パネル3の側面下端部43には、正面パネル3に直交するようにキャスター取付台51が取付けられ、キャスター11は、キャスター取付台51の両端部に取付けられている。同様に側面パネル5の側面下端部47にも、側面パネル5に直交するようにキャスター取付台53が取付けられ、キャスター11は、キャスター取付台53の両端部に取付けられている。正面パネル3の側面下端部45及び側面パネル5の側面下端部49には、それぞれのパネルに1つのキャスター11が取付けられている。キャスター11は、360度いずれの方向にも回転可能な公知のキャスターである。正面パネル3と側面パネル5とは直交するように配置されているので、正面パネル3及び側面パネル5に設けられたキャスター取付台51、53は直交する。このため互いのキャスター11が移動を邪魔しないように360度回転可能でいずれの方向にも移動可能な自在キャスターを使用する。キャスター11は、正面パネル3、側面パネル5の重量に応じた公知のキャスターを使用可能であり、特にストッパー付きのキャスターが好ましい。放射性薬剤を被験者100に投与するとき腕104が動くと、注射針202が抜け、あるいは放射性薬剤が漏洩する恐れがあるので、腕104を置くテーブル7、9、つまり放射線被曝防護装置1が動かないことが好ましい。このため放射線被曝防護装置1を設置した後は、動かないようにキャスター11をロックさせることが好ましい。また、放射線被曝防護装置1が動かないようにするために、高さを調整可能なアジャスターを取付け、放射線被曝防護装置1を設置した後は、キャスター11が床面55に接地しないようにしてもよい。   The casters 11 are provided at both side lower ends 43 and 45 of the front panel 3 and both side lower ends 47 and 49 of the side panel 5. A caster mounting base 51 is attached to the lower side surface 43 of the front panel 3 so as to be orthogonal to the front panel 3, and the casters 11 are attached to both ends of the caster mounting base 51. Similarly, the caster mounting base 53 is attached to the side surface lower end portion 47 of the side panel 5 so as to be orthogonal to the side panel 5, and the casters 11 are attached to both ends of the caster mounting base 53. One caster 11 is attached to each of the side surface lower end 45 of the front panel 3 and the side lower end 49 of the side panel 5. The caster 11 is a known caster that can rotate in any direction of 360 degrees. Since the front panel 3 and the side panel 5 are arranged so as to be orthogonal to each other, the caster mounting bases 51 and 53 provided on the front panel 3 and the side panel 5 are orthogonal to each other. For this reason, a universal caster that can rotate 360 degrees and can move in any direction is used so that the casters 11 do not interfere with the movement. As the caster 11, a known caster corresponding to the weight of the front panel 3 and the side panel 5 can be used, and a caster with a stopper is particularly preferable. If the arm 104 moves when the radiopharmaceutical is administered to the subject 100, the injection needle 202 may come off or the radiopharmaceutical may leak, so the tables 7, 9 on which the arm 104 is placed, that is, the radiation exposure protection device 1 does not move. It is preferable. For this reason, after installing the radiation exposure protection apparatus 1, it is preferable to lock the caster 11 so as not to move. Further, in order to prevent the radiation exposure protection device 1 from moving, an adjuster capable of adjusting the height is attached, and after the radiation exposure protection device 1 is installed, the caster 11 may not be grounded to the floor surface 55. Good.

放射線被曝防護装置1は、さらに被験者100の体内に放射性薬剤が入ったことを確認するため、被験者100から放出される放射線量を測定するための放射線量測定装置を備える。放射線量測定装置は、被験者100から放出される放射線量を測定する検出器57、放射線量を表示する表示器59を備え、検出器57はテーブル7の裏面に固定され、表示器59は、テーブル9上に置かれている。このように検知器57及び表示器59を設けることで、医療従事者110は被曝することなく被験者100の体内に放射性薬剤が入ったことを確認することができる。なお、検出器57及び表示器59の位置は本実施形態に示す位置に限定されるものではなく、検出器57は正面パネル3の表側で被験者100の体に近い位置、表示器59は、正面パネル3の裏側で医療従事者110が見やすい位置であればよい。放射線量測定装置は、被験者100から放出される放射線量を測定可能で、検出器57と表示器59とを分離可能な公知の放射線量測定装置を使用することができる。なお、固定式の放射線量測定装置に代え、持ち運び自在な放射線量測定装置を使用することもできる。   The radiation exposure protection apparatus 1 further includes a radiation dose measuring device for measuring the radiation dose emitted from the subject 100 in order to confirm that the radiopharmaceutical has entered the body of the subject 100. The radiation dose measuring apparatus includes a detector 57 for measuring the radiation dose emitted from the subject 100 and a display 59 for displaying the radiation dose. The detector 57 is fixed to the back surface of the table 7. 9 is placed on top. By providing the detector 57 and the indicator 59 in this manner, the medical worker 110 can confirm that the radiopharmaceutical has entered the body of the subject 100 without being exposed. The positions of the detector 57 and the display 59 are not limited to the positions shown in this embodiment. The detector 57 is a position close to the body of the subject 100 on the front side of the front panel 3, and the display 59 is the front. Any position may be used as long as the medical worker 110 can easily see the back side of the panel 3. As the radiation dose measuring device, a known radiation dose measuring device capable of measuring the radiation dose emitted from the subject 100 and capable of separating the detector 57 and the display 59 can be used. Instead of a fixed radiation dose measuring device, a portable radiation dose measuring device can also be used.

放射線被曝防護装置1の使用例を示す。側面パネル5の外側であって、側面パネル5の開口部20から操作し易い位置に放射性薬剤投与装置200を設置する。被験者100は、正面パネル3の表面31に対面するように椅子130に着座し、正面パネル3の開口部19にいずれか1方の腕104を差し入れる。医療従事者110は、正面パネル3の裏側に位置し、開口部19から差し込まれた被験者100の腕104に放射性薬剤を投与するための注射針202を刺す。このとき、放射性薬剤投与装置200と注射針202とを結ぶチューブ204は、正面パネル3の表側を通し、開口部19から注射針202を正面パネル3の裏側に入れる。医療従事者110は、注射針202を刺した後、放射性薬剤投与装置200を操作し、放射性薬剤を投与する。放射性薬剤を投与中、医療従事者110は、正面パネル3の裏側で椅子132に着座し、放射性薬剤の投与状態を視認すると共に、表示器59を確認する。投与終了後、医療従事者110は注射針202を外し、被験者100は別室で安静にする。投与終了後、医療従事者110は、側面パネル5の表側に回り、使用済みのチューブ204及び注射針202を新しいチューブ及び注射針に交換する。   The usage example of the radiation exposure protection apparatus 1 is shown. The radiopharmaceutical administration device 200 is installed outside the side panel 5 at a position where it can be easily operated from the opening 20 of the side panel 5. The subject 100 sits on the chair 130 so as to face the surface 31 of the front panel 3 and inserts one of the arms 104 into the opening 19 of the front panel 3. The medical worker 110 is located on the back side of the front panel 3 and pierces the injection needle 202 for administering the radiopharmaceutical into the arm 104 of the subject 100 inserted through the opening 19. At this time, the tube 204 connecting the radiopharmaceutical administration device 200 and the injection needle 202 passes through the front side of the front panel 3, and inserts the injection needle 202 into the back side of the front panel 3 from the opening 19. The medical worker 110 operates the radiopharmaceutical administration device 200 after puncturing the injection needle 202 and administers the radiopharmaceutical. During the administration of the radiopharmaceutical, the medical worker 110 sits on the chair 132 behind the front panel 3, visually confirms the administration state of the radiopharmaceutical, and checks the display 59. After the administration, the medical staff 110 removes the injection needle 202, and the subject 100 rests in a separate room. After the administration, the medical staff 110 turns to the front side of the side panel 5 and replaces the used tube 204 and the injection needle 202 with a new tube and injection needle.

以上のように医療従事者110は、正面パネル3及び側面パネル5の内側で放射性薬剤投与装置200を操作し、被験者100の観察を行うことができるので、放射線被曝が低減される。投与終了後、医療従事者110は、側面パネル5の表側に出て行き、使用済みのチューブ204及び注射針202を新しいチューブ204及び注射針202に交換するが、このときは、放射線は放出していないので被曝することはない。また上記のように医療従事者110は、正面パネル3及び側面パネル5の内側で放射性薬剤投与装置200の操作、注射針202の挿入及び被験者100の観察を行うことができるので殆ど移動する必要がなく、作業性に優れる。   As described above, the medical staff 110 can operate the radiopharmaceutical administration device 200 inside the front panel 3 and the side panel 5 to observe the subject 100, so that radiation exposure is reduced. After the administration is completed, the medical worker 110 goes out to the front side of the side panel 5 and replaces the used tube 204 and the injection needle 202 with a new tube 204 and the injection needle 202. At this time, radiation is emitted. It is not exposed because it is not. Further, as described above, the medical worker 110 can operate the radiopharmaceutical administration device 200, insert the injection needle 202, and observe the subject 100 inside the front panel 3 and the side panel 5, and therefore needs to move almost. There is no workability.

また放射線被曝防護装置1に、放射性薬剤を投与中の被験者100の腕を覆う腕カバー80を含めることが好ましい。図6に腕カバー80の斜視図を示す。腕カバー80は、細長い直方体の箱状の本体82と本体82の上面(天面)に取付けられた取っ手84からなる。本体80は、底面及び正面が開口し、底面及び正面を除く4面は、透明な放射線遮蔽板からなる。この放射線遮蔽板は、腕カバー80で覆われた被験者100の腕104、チューブ204及び注射針202を視認可能で、放射性薬剤を投与中の被験者の腕104、チューブ204及び注射針202から放出される放射線を遮蔽できる放射線遮蔽性能を備える。このような放射線遮蔽板は、正面パネル3の上半面の放射線遮蔽板13と同様、公知の含鉛アクリル板、含鉛プラスチック板、放射線遮蔽用鉛ガラスなどを使用することができる。腕カバー80の大きさは、被験者100が正面パネル3の開口部19に腕を差し入れたとき、正面パネル3の裏側に出ている腕104を覆うことができる大きさで、かつ開口部19を塞ぐことのできる大きさである。このような腕カバー80を使用し、放射性薬剤を投与中の被験者100の腕104を覆いかつ開口部19を塞ぐことで、医療従事者110は、被曝をより低減させた状態で被験者100に放射性薬剤が投与されていることを視認することができる。   The radiation exposure protection device 1 preferably includes an arm cover 80 that covers the arm of the subject 100 who is administering the radiopharmaceutical. FIG. 6 shows a perspective view of the arm cover 80. The arm cover 80 includes an elongated rectangular parallelepiped box-shaped main body 82 and a handle 84 attached to the upper surface (top surface) of the main body 82. The main body 80 is open at the bottom and front, and the four surfaces excluding the bottom and front are made of a transparent radiation shielding plate. The radiation shielding plate can visually recognize the arm 104, the tube 204, and the injection needle 202 of the subject 100 covered with the arm cover 80, and is released from the arm 104, the tube 204, and the injection needle 202 of the subject who is administering the radiopharmaceutical. It has radiation shielding performance that can shield radiation. As such a radiation shielding plate, a known lead-containing acrylic plate, a lead-containing plastic plate, lead glass for radiation shielding, and the like can be used similarly to the radiation shielding plate 13 on the upper half of the front panel 3. The size of the arm cover 80 is a size that can cover the arm 104 protruding on the back side of the front panel 3 when the subject 100 inserts his arm into the opening 19 of the front panel 3. It is a size that can be closed. Using such an arm cover 80, the medical worker 110 covers the arm 104 of the subject 100 who is administering the radiopharmaceutical and closes the opening 19, so that the medical staff 110 radioactively reduces the exposure to the subject 100. It can be visually confirmed that the drug is being administered.

上記のように本発明の放射線被曝防護装置1は、正面パネル3の一部を透明な放射性遮蔽板13とし、医療従事者110が正面パネル3の内側から被験者100の様子又は放射性薬剤投与の様子を視認可能とした点が特徴の1つとなっている。正面パネル3の一部を透明な放射性遮蔽板13とする方法は、上記実施形態に示す方法に限られず、正面パネル3全体を一枚の金属製の放射性遮蔽板とし、一部に窓を設け、ここに透明な放射性遮蔽板13を取り付けてもよい。医療従事者110が正面パネル3の内側から被験者100の様子又は放射性薬剤投与の様子を視認する場合、透明な放射性遮蔽板が多い方が視認し易いことを考えれば、上記実施形態に示した方法は好ましい方法と言える。また上記実施形態に示す正面パネル3は、製作が容易でかつ安価に製作できる点からも好ましい。このことは側面パネル5にも当てはまる。   As described above, the radiation exposure protection apparatus 1 according to the present invention uses a part of the front panel 3 as the transparent radioactive shielding plate 13, and the medical worker 110 performs the state of the subject 100 or the administration of the radiopharmaceutical from the inside of the front panel 3. One of the features is that can be visually recognized. The method of using a part of the front panel 3 as the transparent radioactive shielding plate 13 is not limited to the method described in the above embodiment, and the entire front panel 3 is a single metal radioactive shielding plate, and a window is provided in a part thereof. A transparent radioactive shielding plate 13 may be attached here. When the medical worker 110 visually recognizes the state of the subject 100 or the state of administration of the radiopharmaceutical from the inside of the front panel 3, the method shown in the above embodiment is considered in view of the fact that the more transparent radioactive shielding plate is visible. Is a preferred method. Moreover, the front panel 3 shown in the said embodiment is preferable also from the point which can be manufactured easily and cheaply. This also applies to the side panel 5.

また本発明の放射線被曝防護装置1は、正面パネル3に被験者100が腕104を差し出す開口部19を設け、この開口部19に合わせてテーブル7、9を設けた点が特徴の1つとなっている。開口部19の穿設要領は、被験者100が腕104を差し出し易い位置、大きさであれば、上記実施形態に示す要領に限られず、例えば、金属製の放射線遮蔽板15の上部、又は透明な放射線遮蔽板13と金属製の放射線遮蔽板15とに跨るように設けてもよい。但し、加工の容易性、開口部19に差し込まれた腕104の視認性の点から、上記実施形態に示すように透明な放射線遮蔽板13の下部に開口部19を設けることが好ましい。このことは側面パネル5の開口部20の穿設要領にも当てはまる。   In addition, the radiation exposure protection apparatus 1 of the present invention is characterized in that the front panel 3 is provided with an opening 19 through which the subject 100 pushes out the arm 104 and the tables 7 and 9 are provided in accordance with the opening 19. Yes. The drilling procedure of the opening 19 is not limited to the procedure described in the above embodiment as long as the subject 100 can easily put out the arm 104, and is not limited to the procedure shown in the above embodiment, for example, the upper part of the metal radiation shielding plate 15 or transparent You may provide so that the radiation shielding board 13 and the metal radiation shielding board 15 may be straddled. However, from the viewpoint of ease of processing and visibility of the arm 104 inserted into the opening 19, it is preferable to provide the opening 19 at the lower portion of the transparent radiation shielding plate 13 as shown in the above embodiment. This also applies to the procedure for drilling the opening 20 of the side panel 5.

上記図1から図5と同様の形状からなる以下の大きさの放射線被曝防護装置1を製作し、放射性薬剤を投与するときに使用した。上半面の放射性遮蔽板13には、厚さ70mm、幅800mm、高さ650mmの含鉛アクリル板、下半面の放射性遮蔽板15には、厚さ10mmの鉛板を中央に配置し両側にステンレス板を配置した、厚さ70mm、幅800mm、高さ700mmの放射性遮蔽板を使用し、これらを上下に配置し高さ(キャスター込み)1400mm、幅は800mm、厚さは70mmの正面パネル3とした。同様に上部の放射性遮蔽板14には、厚さ70mm、幅800mm、高さ500mmの含鉛アクリル板、下部の放射性遮蔽板16には、厚さ5mmの鉛板を中央に配置し両側にステンレス板を配置した、厚さ70mm、幅800mm、高さ850mmの放射性遮蔽板を使用し、高さ(キャスター込み)1400mm、幅は800mm、厚さは70mmの側面パネル5とした。正面パネル3に設けた開口部19は、高さ200mm、幅250mm、側面パネル5に設けた開口部20は、高さ250mm、幅は放射性薬剤投与装置200と同じ500mmとした。   A radiation exposure protection device 1 having the same shape as that shown in FIGS. 1 to 5 and having the following size was manufactured and used when a radiopharmaceutical was administered. The upper half of the radioactive shielding plate 13 is a lead-containing acrylic plate having a thickness of 70 mm, a width of 800 mm and a height of 650 mm, and the lower half of the radioactive shielding plate 15 is a lead plate having a thickness of 10 mm in the center and stainless steel on both sides. A front panel 3 having a thickness of 70 mm, a width of 800 mm, and a height of 700 mm is used, and these are arranged up and down to a height (including casters) of 1400 mm, a width of 800 mm, and a thickness of 70 mm. did. Similarly, a lead-containing acrylic plate having a thickness of 70 mm, a width of 800 mm, and a height of 500 mm is disposed on the upper radioactive shielding plate 14, and a lead plate having a thickness of 5 mm is disposed in the center on the lower radioactive shielding plate 16, and stainless steel is provided on both sides. A radiation shielding plate having a thickness of 70 mm, a width of 800 mm, and a height of 850 mm was used, and a side panel 5 having a height (including casters) of 1400 mm, a width of 800 mm, and a thickness of 70 mm was used. The opening 19 provided in the front panel 3 has a height of 200 mm and a width of 250 mm, and the opening 20 provided in the side panel 5 has a height of 250 mm and a width of 500 mm, which is the same as that of the radiopharmaceutical administration device 200.

この放射線被曝防護装置1の側面パネル5の外側で開口部20の位置に合わせ放射性薬剤投与装置200を設置し、放射性薬剤投与装置200を介して、被験者100に放射性薬剤を投与した。このときの複数の医療機関において、約30名の医療従事者の被曝線量を半年以上に亘り測定した。各医療従事者は、1日当たり7〜8名の被験者100に放射性薬剤投与を投与する。医療従事者1名の1月当たりの被曝線量は、フィルムバッチから算出したところ、最大で約0.4ミリシーベルト、大半はフィルムバッチの測定下限である0.1ミリシーベルト又は測定下限値以下であった。   A radiopharmaceutical administration device 200 was installed outside the side panel 5 of the radiation exposure protection apparatus 1 in accordance with the position of the opening 20, and the radiopharmaceutical was administered to the subject 100 via the radiopharmaceutical administration device 200. At a plurality of medical institutions at this time, the exposure dose of about 30 medical workers was measured over a half year. Each medical worker administers radiopharmaceutical administration to 7 to 8 subjects 100 per day. The monthly exposure dose for one health care worker is calculated from a film batch, and is about 0.4 millisievert at the maximum. It was the following.

1 放射線被曝防護装置
3 正面パネル
5 側面パネル
7、9 テーブル
11 キャスター
13 放射線遮蔽板
14 放射線遮蔽板
15 放射線遮蔽板
16 放射線遮蔽板
19 開口部
20 開口部
21a、21b ステンレス板
22a、22b ステンレス板
31 正面パネルの表面
32 正面パネルの裏面
33 側面パネルの表面
34 側面パネルの裏面
35 放射線遮蔽板の下端
39 正面パネルと側面パネルとの継ぎ目
57 検出器
59 表示器
80 腕カバー
100 被験者
104 被験者の腕
110 医療従事者
130 椅子
200 放射性薬剤投与装置
202 注射針
204 チューブ
DESCRIPTION OF SYMBOLS 1 Radiation exposure protection apparatus 3 Front panel 5 Side panel 7, 9 Table 11 Caster 13 Radiation shielding board 14 Radiation shielding board 15 Radiation shielding board 16 Radiation shielding board 19 Opening part 20 Opening part 21a, 21b Stainless steel board 22a, 22b Stainless steel board 31 Front panel surface 32 Front panel back surface 33 Side panel surface 34 Side panel back surface 35 Lower end of radiation shielding plate 39 Joint between front panel and side panel 57 Detector 59 Display 80 Arm cover 100 Subject 104 Subject's arm 110 Medical staff 130 Chair 200 Radiopharmaceutical administration device 202 Injection needle 204 Tube

Claims (5)

放射性薬剤投与装置を介して被験者に放射性薬剤を投与する際に使用する、移動可能な衝立式の放射線被曝防護装置であって、
椅子に着座した被験者が腕を挿入する開口部が設けられた放射線を遮蔽する正面パネルと、
放射性薬剤投与装置の高さに合わせて設けられた放射性薬剤投与装置を操作可能な開口部を有する放射線を遮蔽する側面パネルと、
前記正面パネルに設けられた開口部の下端部の位置に合わせ、前記正面パネルの表裏に取付けられた被験者の腕を置くためのテーブルと、
前記正面パネル及び側面パネルの下部に設けられたキャスターと、を含み、
前記正面パネル及び側面パネルは共に、少なくとも開口部の下端から上部が透明であり、前記正面パネルと側面パネルがL字状に配置、連結されていることを特徴とする放射線被曝防護装置。
A movable screen-type radiation exposure protection device for use in administering a radiopharmaceutical to a subject via a radiopharmaceutical administration device,
A front panel that shields radiation provided with an opening through which a subject sitting on a chair inserts an arm;
A side panel that shields radiation having an opening capable of operating the radiopharmaceutical administration device provided according to the height of the radiopharmaceutical administration device;
In accordance with the position of the lower end of the opening provided in the front panel, a table for placing the subject's arms attached to the front and back of the front panel;
A caster provided at a lower portion of the front panel and the side panel,
Both the front panel and the side panel are transparent at least from the lower end of the opening, and the front panel and the side panel are arranged and connected in an L shape.
前記正面パネルは、上半面が透明な放射線遮蔽板、下半面が不透明な放射線遮蔽板からなり、上半面を覆う放射線遮蔽板の下部に前記開口部が設けられ、
前記側面パネルは、上方部が透明な放射線遮蔽板、他部が不透明な放射線遮蔽板からなり、上方部放射線遮蔽板の下部に前記開口部が設けられていることを特徴とする請求項1に記載の放射線被曝防護装置。
The front panel is composed of a radiation shielding plate whose upper half surface is transparent and a radiation shielding plate whose lower half surface is opaque, and the opening is provided below the radiation shielding plate covering the upper half surface,
2. The side panel according to claim 1, wherein the side panel includes a transparent radiation shielding plate in an upper portion and an opaque radiation shielding plate in the other portion, and the opening is provided in a lower portion of the upper radiation shielding plate. The radiation exposure protection device described.
前記正面パネルにおいて被験者が対面する方を表側、その反対側を裏側としたとき、
前記正面パネルと前記側面パネルの継ぎ目が前記正面パネルの裏側になるように、前記正面パネルと前記側面パネルが配置、連結されていることを特徴とする請求項1又は2に記載の放射線被曝防護装置。
When the front side faces the subject in the front panel, the opposite side is the back side,
The radiation exposure protection according to claim 1 or 2, wherein the front panel and the side panel are arranged and connected so that a joint between the front panel and the side panel is located on the back side of the front panel. apparatus.
さらに放射性薬剤を投与中の被験者の腕に上方から被せ使用する、透明な放射線遮蔽板で形成された腕カバーを含むことを特徴とする請求項1から3のいずれか1に記載の放射線被曝防護装置。   The radiation exposure protection according to any one of claims 1 to 3, further comprising an arm cover formed of a transparent radiation shielding plate, which is used by covering the arm of a subject who is administering a radiopharmaceutical from above. apparatus. 前記正面パネルにおいて被験者が対面する方を表側、その反対側を裏側としたとき、
さらに前記正面パネルの表側中央部に設置され、被験者の体内から放出される放射線量を測定する放射線量検出器と、
前記正面パネルの裏側に設置され、前記放射線量検出器で測定した放射線量を表示する表示器と、
を含むことを特徴とする請求項1から4のいずれか1に記載の放射線被曝防護装置。
When the front side faces the subject in the front panel, the opposite side is the back side,
Furthermore, a radiation dose detector that is installed in the front center part of the front panel and measures the radiation dose emitted from the body of the subject,
A display installed on the back side of the front panel and displaying the radiation dose measured by the radiation dose detector;
The radiation exposure protection apparatus according to claim 1, wherein the radiation exposure protection apparatus comprises:
JP2010182700A 2010-08-18 2010-08-18 Radiation exposure protection device Expired - Fee Related JP5626975B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010182700A JP5626975B2 (en) 2010-08-18 2010-08-18 Radiation exposure protection device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010182700A JP5626975B2 (en) 2010-08-18 2010-08-18 Radiation exposure protection device

Publications (2)

Publication Number Publication Date
JP2012042292A JP2012042292A (en) 2012-03-01
JP5626975B2 true JP5626975B2 (en) 2014-11-19

Family

ID=45898799

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010182700A Expired - Fee Related JP5626975B2 (en) 2010-08-18 2010-08-18 Radiation exposure protection device

Country Status (1)

Country Link
JP (1) JP5626975B2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE8807462U1 (en) * 1988-06-08 1989-10-05 Siemens Ag, 1000 Berlin Und 8000 Muenchen, De
JP3025589U (en) * 1995-08-16 1996-06-21 峰崇 堺 Radioisotope shield for radioisotope injection
JP2001120543A (en) * 1999-10-28 2001-05-08 Fukuyama Kenkosha:Kk X-ray protective panel for medical examination table
FR2838862B1 (en) * 2002-04-17 2004-09-10 Lemer Pax PROTECTIVE SCREEN AGAINST IONIZING RADIATION EMISSIONS

Also Published As

Publication number Publication date
JP2012042292A (en) 2012-03-01

Similar Documents

Publication Publication Date Title
US10991474B2 (en) Shielding assemblies for infusion systems
US8708352B2 (en) Cabinet structure configurations for infusion systems
KR101861389B1 (en) Activity delivery progress monitor
US7862534B2 (en) Infusion circuit subassemblies
RU2756817C2 (en) Mobile radiation protection screen
US20090312630A1 (en) Infusion systems including computer-facilitated maintenance and/or operation and methods of use
WO2005099373A2 (en) Radiation barrier
JP5626975B2 (en) Radiation exposure protection device
JP2006275610A (en) Radiation shielding panel device
JP3936646B2 (en) PET facility
JP4440904B2 (en) Wheelchair with exposure prevention function and medical consultation facility system using the same
CN217659914U (en) NICU radiation protection device
JP2011247885A (en) Vial shield
CN211355555U (en) Radiology department examination protection device
CN213372058U (en) Rotation respiratory tube access structure from shielding CT
Cruzate et al. Shielding of medical facilities. Shielding design considerations for PET-CT facilities
CN213372053U (en) Breathing tube access structure of self-shielding CT
JP2006296917A (en) Human body transferring vehicle
US11547798B2 (en) Installation for the injection of a radioactive product into a patient and method for the implementation thereof
CN101904750B (en) Medical ray radiation protection cover for bone density detection
JP3033001U (en) X-ray protection screen
JPH0871064A (en) X-ray ct apparatus
Jones et al. Design of a Suitable Facility to House a SPECT/CT Scanner
Rosenbloom et al. Radiation Protection of Staff and the Public
JP2015052473A (en) Design method for radiation shielding wall, radiation shielding wall, and hospital room including the radiation shielding wall

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130730

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140710

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140811

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140926

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140926

R150 Certificate of patent or registration of utility model

Ref document number: 5626975

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees